Sensi Brands Secures Major Cultivation Site in Bid for Overseas Expansion

RICHMOND HILL – Sensi Brands Inc. completed its purchase of Maricann Inc., gaining control of a sprawling production facility tailored for export markets. The deal, the company’s biggest to date, centers on a 100-acre campus in Langton, Ontario, complete with a 350,000-square-foot hybrid greenhouse built to EU-GMP standards.

The property holds potential for expansion up to 1.1 million square feet of growing space, with current operations geared to yield 30,000 kilograms of dried flower each year once fully certified. Plans call for adding outdoor plots to boost output by 10,000 kilograms next year and double that the following year. Maricann, licensed since 2014, had changed hands before, most recently in 2020 when it went to CanAdelaar Group and served as a supplier for medical Cannabis exports through a lease.

For Sensi Brands, the move addresses key pressures in the domestic industry, where producers face tighter capacity and a wave of mergers amid steady wholesale price drops. The firm, already distributing more than 350 products across nine provinces through hits like its top-selling pre-rolls and flower packs, now locks in a reliable source for high-grade material. Founder and Chief Executive Tony Giorgi described the step as essential for steady supply to back the company’s brands at home while opening doors abroad. “This gives us the scale to meet our commitments here and start building real traction overseas,” he said in a statement.

Beyond Canada, the EU-compliant setup positions Sensi to tap into promising outlets in Europe, Australia and even the United States, where demand for certified medical Cannabis continues to climb. Executives highlighted early talks with distributors and operators for bulk deals, private labeling and joint ventures, signaling a shift from purely local focus. The acquisition fits a broader pattern among Canadian firms chasing higher margins through cross-border sales, especially as homegrown recreational volumes stabilize after years of oversupply.

Details on the purchase price remain under wraps, though sources peg it as a multimillion-dollar transaction reflective of current asset values in a maturing market. Sensi, privately held and known for profitability in an often-unprofitable field, maintains operations from cultivation to retail, including a clinic and online medical shop.

As consolidations reshape the sector, this one underscore how forward-thinking operators are fortifying their bases for the next phase of trade. Sensi Brands emerges stronger, with the tools to compete on quality and volume, a smart play that could redefine export dynamics. However, the ultimate challenge involves execution: translating facility specs into signed contracts and steady revenue streams that propel the entire Canadian contingent to the global stage forefront.